GovWire

Research: Valproate: Managing reproductive risks in male patients under 55

⌂Back To Homepage Subscribe To RSS Feed

Medicines Healthcare Products Regulatory Agency
February 13
14:42 2025
Print This Article Share it With Friends

class="gem-c-govspeak govuk-govspeak gem-c-govspeak--direction-ltr govuk-!-margin-bottom-0">

This report presents the current risk minimisation measures in place for men under 55 years taking valproate and the advice of the CHM on whether further regulatory action is appropriate.

Updates to this page

Published 13 February 2025

Sign up for emails or print this page